3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
155
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma
25
Lymphoma, Non-Hodgkin
23
Lymphoma, Mantle-Cell
23
Lymphoma, Follicular
23
Leukemia
22
Recurrence
21
Neoplasms, Plasma Cell
19
Myelodysplastic Syndromes
12
Lymphoma, B-Cell, Marginal Zone
12
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
8
Smoldering Multiple Myeloma
8
Hodgkin Disease
8
Prostatic Neoplasms
7
Lymphoma, B-Cell
6
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Hematologic Diseases
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Leukemia, Myelomonocytic, Chronic
4
Immunoblastic Lymphadenopathy
4
Anemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Lymphoma, T-Cell, Cutaneous
3
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Lenalidomide
×
Clear all
No trials found.